Field note · July 2026

What a compliance citation actually starts

An OSHA citation or an FDA warning letter reads, from the outside, like paperwork. Inside the company that received it, it reads like a countdown. A remediation window opens, a regulator is now watching, and the vendors, suppliers, or partners who were merely acceptable yesterday are, overnight, not enough.

Almost nobody outside the compliance team notices this moment happen. Most B2B outreach still runs on a calendar — quarterly check-ins, annual RFPs — while the actual opportunity runs on the regulator's clock, which doesn't wait for anyone's outreach cadence.

The company doesn't need a new partner eventually. It needs one before the next inspection.

That gap — between when the need becomes real and when the market notices it — is where an introduction is worth the most and costs the least to make. It's also why the same handful of public sources — warning letters, citations, restructuring filings — are worth reading closely rather than once a quarter.

None of this requires inside information. It requires watching the public record closely enough to be early, and having someone worth introducing the moment the window opens.

— Robbert van Dommelen routes B2B introductions wherever two sides are already circling the same conclusion.